Partners in Discovery Blog

During my PhD at UBC, I became convinced of a notion that had been known for decades: “cancer is a disease of the genome”. So naturally, to further our understanding of cancer, the genomes of tumours would need to be precisely decoded.

Frustratingly, technology did not yet exist to study individual tumours in this way. After all, it took the human genome project billions of dollars, 15...

What a month! April was an exciting month for milestone achievements at the BC Cancer Agency. On April 22, the Agency’s own Dr. Karen Gelmon was honoured for her contributions to breast cancer research and her new partnership with Israeli scientists at the Institute for Medical Research Israel-Canada (IMRIC) at a sold-out gala event co-hosted by the Canadian Friends of the Hebrew University of...

By the early 2000s the BC Cancer Agency clinical care programs reflected all we had learned from careful collection of the clinical records of thousands of patients over more than two decades of clinical research.

Pooling our extensive records and our rich collection of biopsy materials, we participated in the research efforts that were uncovering new insights into lymphoid cancer...

Throughout the 1980s and '90s, the BC Cancer Agency’s lymphoma research group grew steadily. Clinical staff in Medical Oncology, Radiation Oncology and Pathology conducted research projects that helped define internationally recognized treatment policies for Hodgkin lymphoma, non-Hodgkin lymphoma, lymphocytic leukemia and myeloma.

We participated in and led national and international...